← FDA Drug Approvals (Drugs@FDA)

TRIAMTERENE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: BIOCON GENERICS · Approved 2022-07-06

Drug application

FDA Application #

ANDA214768

Application type

Abbreviated New Drug Application (Generic)

Brand name

TRIAMTERENE

Generic name

TRIAMTERENE

Active ingredients

TRIAMTERENE

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

BIOCON GENERICS

Manufacturer

Biocon Pharma Inc.

First approval

2022-07-06

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown